Patients treated with ligelizumab achieve freedom fromsigns and symptoms of chronic spontaneous urticaria regardless of the angioedema status at baseline

被引：0
|
作者：
Sitz, Karl [1 ]
Soong, Weily [2 ]
Bernstein, Jonathan A. [3 ,4 ]
机构：
[1] Little Rock Allergy & Asthma Clin, Little Rock, AR USA
[2] AllerVie Hlth, Alabama Allergy & Asthma Ctr, Clin Res Ctr Alabama, Birmingham, AL USA
[3] Univ Cincinnati, Coll Med, Cincinnati, OH USA
[4] Bernstein Clin Res Ctr, Cincinnati, OH USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2022年 / 87卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
33583
引用
收藏
页码：AB90 / AB90
页数：1
相关论文
共 50 条
  • [41] Dupilumab Improves Urticaria Signs and Symptoms and Quality of Life in Patients With Chronic Spontaneous Urticaria (CSU)
    Maurer, Marcus
    Casale, Thomas B.
    Saini, Sarbjit S.
    Ben-Shoshan, Moshe
    Radin, Allen
    Bauer, Deborah
    Thomas, Ryan B.
    Mannent, Leda P.
    Stjepanovic, Aleksandra
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB40 - AB40
  • [42] Complete freedom from chronic spontaneous urticaria signs and symptoms is associated with sleep and dermatology quality-of-life improvements: Data from the phase 2b ligelizumab study
    Bernstein, Jonathan A.
    Gimenez-Arnau, Ana
    Hide, Michihiro
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB35 - AB35
  • [43] LIGELIZUMAB REDUCES RESCUE MEDICATION USE IN PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA: PHASE 2B STUDY RESULTS
    Sitz, K.
    Soong, W.
    Lanier, B.
    Kobayashi, K.
    Barve, A.
    Hua, E.
    Janocha, R.
    Severin, T.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S28 - S28
  • [44] TIME TO SLEEP IMPROVEMENT IN PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA TREATED WITH OMALIZUMAB
    Mosnaim, G.
    Holden, M.
    Trzaskoma, B.
    Gimenez-Arnau, A.
    Casale, T.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S36 - S36
  • [45] Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status
    Thomas B. Casale
    Ana Maria Gimenez-Arnau
    Jonathan A. Bernstein
    Michael Holden
    Torsten Zuberbier
    Marcus Maurer
    Dermatology and Therapy, 2023, 13 : 2573 - 2588
  • [46] Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status
    Casale, Thomas B.
    Gimenez-Arnau, Ana Maria
    Bernstein, Jonathan A.
    Holden, Michael
    Zuberbier, Torsten
    Maurer, Marcus
    DERMATOLOGY AND THERAPY, 2023, 13 (11) : 2573 - 2588
  • [47] Omalizumab effectively reduces angioedema episodes in patients with chronic idiopathic/spontaneous urticaria (CIU/CSU)
    Staubach, P.
    Metz, M.
    Chapman-Rothe, N.
    Sieder, C.
    Braeutigam, M.
    Canvin, J.
    Maurer, M.
    EXPERIMENTAL DERMATOLOGY, 2016, 25 : 18 - 18
  • [48] Montelukast reduces symptom severity and frequency in patients with angioedema-predominant chronic spontaneous urticaria
    Akenroye, Ayobami T.
    McEwan, Conor
    Saini, Sarbjit S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2018, 6 (04): : 1403 - 1405
  • [49] The association between sexual dysfunctions and severity of symptoms in patients with chronic spontaneous urticaria
    Agnieszka Skrzypulec-Frankel
    Katarzyna Bieniek
    Alicja Kasperska-Zając
    Allergy, Asthma & Clinical Immunology, 14
  • [50] Quality of Life, Disease Burden and subjective Symptoms of Patients with chronic spontaneous Urticaria
    Langenbruch, A.
    Kressel, N.
    Braun, V
    Maurer, M.
    Reich, K.
    Augustin, M.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 113 - 114
12345